ATE331525T1 - Salzformarme polyallylamine - Google Patents

Salzformarme polyallylamine

Info

Publication number: ATE331525T1
Authority: AT; Austria
Prior art keywords: polyallylamines; salt form; low salt; polymer; diluent
Prior art date: 2001-04-18

Application number

AT02721716T

Other languages

English (en)

Inventor

John S Petersen

Steven Keith Burke

Stephen Randall Holmes-Farley

Original Assignee

Genzyme Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-18

Filing date

2002-04-10

Publication date

2006-07-15

2002-04-10 Application filed by Genzyme Corp filed Critical Genzyme Corp

2006-07-15 Application granted granted Critical

2006-07-15 Publication of ATE331525T1 publication Critical patent/ATE331525T1/de

Links

229920000642 polymer Polymers 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
229920002518 Polyallylamine hydrochloride Polymers 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Medicinal Preparation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT02721716T 2001-04-18 2002-04-10 Salzformarme polyallylamine ATE331525T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US28444501P	2001-04-18	2001-04-18

Publications (1)

Publication Number	Publication Date
ATE331525T1 true ATE331525T1 (de)	2006-07-15

Family

ID=23090248

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02721716T ATE331525T1 (de)	2001-04-18	2002-04-10	Salzformarme polyallylamine

Country Status (15)

Country	Link
US (2)	US7541024B2 (de)
EP (1)	EP1379258B1 (de)
JP (2)	JP5170932B2 (de)
KR (1)	KR20040018357A (de)
CN (1)	CN1290515C (de)
AT (1)	ATE331525T1 (de)
AU (1)	AU2002252632B2 (de)
BR (1)	BR0209020A (de)
CA (1)	CA2444587C (de)
DE (1)	DE60212819T2 (de)
ES (1)	ES2268013T3 (de)
MX (1)	MXPA03009572A (de)
NZ (1)	NZ528829A (de)
WO (1)	WO2002085378A1 (de)
ZA (2)	ZA200308063B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6733780B1 (en)	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core
WO2004037274A1 (en) *	2002-10-22	2004-05-06	Genzyme Corporation	Amine polymers for promoting bone formation
WO2005032563A1 (en) *	2003-09-02	2005-04-14	Genzyme Corporation	Method for reducing vascular inflammation
ES2453048T3 (es)	2004-03-30	2014-04-03	Relypsa, Inc.	Polímeros de unión de ión y usos de los mismos
US20060177415A1 (en) *	2004-11-01	2006-08-10	Burke Steven K	Once a day formulation for phosphate binders
US7985418B2 (en)	2004-11-01	2011-07-26	Genzyme Corporation	Aliphatic amine polymer salts for tableting
US8986669B2 (en)	2005-09-02	2015-03-24	Genzyme Corporation	Method for removing phosphate and polymer used therefore
HUE026628T2 (en)	2005-09-15	2016-06-28	Genzyme Corp	Pouches for amine polymers
EP2043627A2 (de) *	2006-07-05	2009-04-08	Genzyme Corporation	Eisen(ii)-haltige behandlungen für hyperphosphatämie
EP2066293A2 (de)	2006-09-29	2009-06-10	Genzyme Corporation	Amid-dendrimer-zusammensetzungen
US8163799B2 (en)	2006-12-14	2012-04-24	Genzyme Corporation	Amido-amine polymer compositions
EP2016947A1 (de)	2007-07-17	2009-01-21	Chemo Ibérica, S.A.	Neuartiges Verfahren zur Herstellung vernetzter Poly(allylamin-)Polymere in einem einzigen Schritt
AU2009235024A1 (en) *	2008-04-08	2009-10-15	Usv Limited	Process for preparation of amine polymer salt
US8404784B2 (en) *	2008-12-03	2013-03-26	Navinta Llc	Manufacturing process of making polymeric amine salts
EP2443157A1 (de) *	2009-06-16	2012-04-25	Watson Pharma Private Limited	Verfahren zur herstellung von sevelamercarbonat
CN105017481B (zh) *	2010-02-24	2018-10-02	瑞立普萨公司	用作胆汁酸螯合剂的交联聚乙烯胺、聚烯丙胺和乙烯亚胺
EP3003327B1 (de) *	2013-06-05	2017-08-09	Tricida Inc.	Protonenbindende polymere zur oralen verabreichung
RS61409B1 (sr)	2014-12-10	2021-03-31	Tricida Inc	Polimeri koji vezuju protone za oralnu primenu opis
CN109414453B (zh)	2016-05-06	2023-02-17	特里赛达公司	用于治疗酸碱失衡的组合物
EP3564292B1 (de)	2016-12-28	2021-06-16	FUJIFILM Corporation	Emulsion eines stickstoffatomhaltigen polymers oder salz davon, herstellungsverfahren dafür und verfahren zur herstellung von partikeln
JP7018451B2 (ja)	2017-10-16	2022-02-10	富士フイルム株式会社	高リン血症治療剤および粒子
CN111225674A (zh)	2017-10-16	2020-06-02	富士胶片株式会社	高磷血症治疗剂
CA3080651A1 (en)	2017-11-03	2019-05-09	Tricida, Inc.	Compositions for and method of treating acid-base disorders
CN110753217B (zh) *	2019-10-28	2022-03-01	黑芝麻智能科技(上海)有限公司	色彩平衡方法和装置、车载设备以及存储介质
US11572355B2 (en) *	2020-07-16	2023-02-07	The Board Of Trustees Of The University Of Alabama	Methods for synthesizing vinylidenes and alkenes
CN112047854B (zh) *	2020-10-20	2021-07-02	中国科学院长春应用化学研究所	一种n-乙烯基烷基酰胺的制备方法
WO2023023938A1 (en) *	2021-08-24	2023-03-02	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Polymers, compositions and methods for treating hyperuricemia
EP4164659B1 (de)	2021-08-24	2024-03-27	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Polymere, zusammensetzungen und verfahren zur behandlung von hyperurikämie

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4222921A (en) *	1978-06-19	1980-09-16	Monsanto Company	Polyamine/epihalohydrin reaction products
JPS6090243A (ja)	1983-10-25	1985-05-21	Nitto Boseki Co Ltd	小球状モノアリルアミン橋かけ重合体の製造方法
US4528347A (en)	1983-11-10	1985-07-09	501 Nitto Boseki, Co. Ltd	Process for producing polymers of monoallylamine
US4614593A (en) *	1985-03-28	1986-09-30	Ethyl Corporation	Demulsification of oil-in-water emulsions
IE914179A1 (en) *	1990-12-07	1992-06-17	Ici Plc	Nitrogen derivatives
US5487888A (en)	1993-05-20	1996-01-30	Geltex, Inc.	Iron-binding polymers for oral administration
US5618530A (en)	1994-06-10	1997-04-08	Geltex Pharmaceuticals, Inc.	Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5703188A (en)	1993-06-02	1997-12-30	Geltex Pharmaceuticals, Inc.	Process for removing bile salts from a patient and compositions therefor
US5624963A (en)	1993-06-02	1997-04-29	Geltex Pharmaceuticals, Inc.	Process for removing bile salts from a patient and compositions therefor
US5900475A (en)	1994-06-10	1999-05-04	Geltex Pharmaceuticals, Inc.	Hydrophobic sequestrant for cholesterol depletion
US5607669A (en) *	1994-06-10	1997-03-04	Geltex Pharmaceuticals, Inc.	Amine polymer sequestrant and method of cholesterol depletion
US5496545A (en)	1993-08-11	1996-03-05	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US5667775A (en)	1993-08-11	1997-09-16	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
TW474813B (en)	1994-06-10	2002-02-01	Geltex Pharma Inc	Alkylated composition for removing bile salts from a patient
WO1996021454A1 (en) *	1995-01-12	1996-07-18	Geltex Pharmaceuticals, Inc.	Phosphate-binding polymers for oral administration
US6203785B1 (en)	1996-12-30	2001-03-20	Geltex Pharmaceuticals, Inc.	Poly(diallylamine)-based bile acid sequestrants
US5925379A (en)	1997-03-27	1999-07-20	Geltex Pharmaceuticals, Inc.	Interpenetrating polymer networks for sequestration of bile acids
JP2003183168A (ja) *	1997-04-04	2003-07-03	Chugai Pharmaceut Co Ltd	リン酸結合性ポリマー含有製剤
TW592727B (en)	1997-04-04	2004-06-21	Chugai Pharmaceutical Co Ltd	Phosphate-binding polymer preparations
US6423754B1 (en) *	1997-06-18	2002-07-23	Geltex Pharmaceuticals, Inc.	Method for treating hypercholesterolemia with polyallylamine polymers
US6726905B1 (en)	1997-11-05	2004-04-27	Genzyme Corporation	Poly (diallylamines)-based phosphate binders
US6083497A (en)	1997-11-05	2000-07-04	Geltex Pharmaceuticals, Inc.	Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US5985938A (en)	1997-11-05	1999-11-16	Geltex Pharmaceuticals, Inc.	Method for reducing oxalate
WO1999040990A1 (en)	1998-02-17	1999-08-19	University Of Maryland	Anion binding polymers and the use thereof
TW568788B (en) *	1998-10-12	2004-01-01	Chugai Pharmaceutical Co Ltd	Polymer combining with phosphoric acid and preparation containing the same
US6180754B1 (en) *	1999-09-03	2001-01-30	The Dow Chemical Company	Process for producing cross-linked polyallylamine polymer
US6733780B1 (en) *	1999-10-19	2004-05-11	Genzyme Corporation	Direct compression polymer tablet core

2002
- 2002-04-10 DE DE60212819T patent/DE60212819T2/de not_active Expired - Lifetime
- 2002-04-10 KR KR10-2003-7013677A patent/KR20040018357A/ko not_active Ceased
- 2002-04-10 AT AT02721716T patent/ATE331525T1/de active
- 2002-04-10 AU AU2002252632A patent/AU2002252632B2/en not_active Ceased
- 2002-04-10 EP EP02721716A patent/EP1379258B1/de not_active Expired - Lifetime
- 2002-04-10 MX MXPA03009572A patent/MXPA03009572A/es active IP Right Grant
- 2002-04-10 JP JP2002582951A patent/JP5170932B2/ja not_active Expired - Fee Related
- 2002-04-10 ES ES02721716T patent/ES2268013T3/es not_active Expired - Lifetime
- 2002-04-10 NZ NZ528829A patent/NZ528829A/en unknown
- 2002-04-10 BR BR0209020-1A patent/BR0209020A/pt not_active IP Right Cessation
- 2002-04-10 WO PCT/US2002/011408 patent/WO2002085378A1/en not_active Ceased
- 2002-04-10 CA CA002444587A patent/CA2444587C/en not_active Expired - Fee Related
- 2002-04-10 CN CNB02808487XA patent/CN1290515C/zh not_active Expired - Fee Related
- 2002-04-17 US US10/125,684 patent/US7541024B2/en not_active Expired - Fee Related
2003
- 2003-10-16 ZA ZA200308063A patent/ZA200308063B/en unknown
- 2003-10-16 ZA ZA200308065A patent/ZA200308065B/en unknown
2009
- 2009-04-21 US US12/427,127 patent/US8377428B2/en not_active Expired - Fee Related
2010
- 2010-02-01 JP JP2010020592A patent/JP5243466B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2002085378A1 (en)	2002-10-31
JP5243466B2 (ja)	2013-07-24
US8377428B2 (en)	2013-02-19
NZ528829A (en)	2006-06-30
EP1379258B1 (de)	2006-06-28
CA2444587C (en)	2008-10-21
DE60212819D1 (de)	2006-08-10
HK1058620A1 (en)	2004-05-28
CN1503676A (zh)	2004-06-09
DE60212819T2 (de)	2006-11-23
US20020159968A1 (en)	2002-10-31
ZA200308065B (en)	2004-09-14
EP1379258A1 (de)	2004-01-14
US7541024B2 (en)	2009-06-02
CN1290515C (zh)	2006-12-20
AU2002252632B2 (en)	2004-09-23
BR0209020A (pt)	2004-08-10
MXPA03009572A (es)	2004-02-12
US20100068167A1 (en)	2010-03-18
JP2010111704A (ja)	2010-05-20
KR20040018357A (ko)	2004-03-03
ES2268013T3 (es)	2007-03-16
ZA200308063B (en)	2005-01-17
CA2444587A1 (en)	2002-10-31
JP2004526777A (ja)	2004-09-02
JP5170932B2 (ja)	2013-03-27

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1379258

Country of ref document: EP

Publication	Publication Date	Title
ATE331525T1 (de)	2006-07-15	Salzformarme polyallylamine
SE0300010D0 (sv)	2003-01-07	Novel Compounds
GEP20074208B (en)	2007-10-10	Substituted amides active at the cannabinoid-1 receptor
DE602004024375D1 (de)	2010-01-14	Carboxamidderivate
PL361341A1 (pl)	2004-10-04	Nowa kompozycja farmaceutyczna
PL350456A1 (en)	2002-12-16	N−cyanomethylamides as protease inhibitors
MXPA05008909A (es)	2005-10-05	Formulacion intranasal de rotigotina.
CY1107850T1 (el)	2013-06-19	Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
BG106366A (en)	2002-08-30	Moxifloxacin formulation containing common salt
MXPA05007609A (es)	2005-09-30	Antagonista de un receptor sensible al calcio.
MY135218A (en)	2008-02-29	2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
DK1383752T3 (da)	2005-10-17	Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
SE0102440D0 (sv)	2001-07-05	New compound
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
SE0300908D0 (sv)	2003-03-31	Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE9802208D0 (sv)	1998-06-22	Novel compounds
SE0302573D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0102055D0 (sv)	2001-06-08	New Compounds
CA2534664A1 (en)	2005-03-17	Modafinil compositions
CA2529441A1 (en)	2005-01-06	Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
SE0302570D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AU2002358819A1 (en)	2003-06-17	Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
SE0302572D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE9802209D0 (sv)	1998-06-22	Novel compounds
SE0001916D0 (sv)	2000-05-23	Novel formulation